Β-Adrenergic agonist administration is not associated with secondary carcinoid crisis in patients with carcinoid tumor

Kristen E. Limbach, Mary E. Condron, Ann E. Bingham, Su Ellen J. Pommier, Rodney F. Pommier

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Background: Patients with carcinoid tumors are at risk for profound intraoperative hypotension known as carcinoid crisis, which catecholamines are traditionally believed to trigger. However, data supporting this are lacking. Methods: Anesthesia records were retrospectively reviewed for carcinoid patients treated with vasopressors. Hemodynamics for those with crisis were compared between those who received β-adrenergic agonists (B-AA) versus those who did not. Results: Among 293 consecutive operations, 58 were marked by 161 crises. There was no significant difference in the incidence of paradoxical hypotension with B-AA compared to non-B-AA (p = 0.242). The maximum percent decrease in mean arterial pressure following drug administration was significantly greater in those patients treated with non-B-AA than with B-AA (31.6% vs. 12.5%, p < 0.0001). There were no differences in crisis duration (p = 0.257) or postoperative complication rate (p = 0.896). Conclusions: β-Adrenergic agonist use was not associated with paradoxical hypotension, prolonged carcinoid crisis, or postoperative complications in patients with intraoperative carcinoid crisis.

Original languageEnglish (US)
JournalAmerican Journal of Surgery
DOIs
StateAccepted/In press - Jan 1 2019

Keywords

  • Carcinoid
  • Carcinoid crisis
  • Epinephrine
  • Vasopressor
  • β-Adrenergic agonist

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Β-Adrenergic agonist administration is not associated with secondary carcinoid crisis in patients with carcinoid tumor'. Together they form a unique fingerprint.

Cite this